Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Carcinoma, Breast”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT06534424
What this trial is testing

Clinical Impact of Enhanced Risk Assessments in Women With a BRCA1/2 Mutation, CARE Study

Who this might be right for
BRCA1/2-Associated Hereditary Breast and Ovarian Cancer Syndrome
Ohio State University Comprehensive Cancer Center 152
Not applicableStudy completedNCT05946759
What this trial is testing

Reoperation Rate in Breast-Conserving Surgery Using Confocal Histolog® Scanner for Intraoperative Margin Assessment

Who this might be right for
Breast Cancer - Ductal Carcinoma in Situ (DCIS)Breast-Conserving Surgery
SamanTree Medical SA 54
Not applicableUnknownNCT05267327
What this trial is testing

A Prospective Post-Marketing Observational Safety Study of Verzenios® (Abemaciclib) Among Breast Cancer Patients in China Verzenios® (Abemaciclib) Among Breast

Who this might be right for
The Incidence of AEs and SAEs Receiving Verzenios® Over a Period of Approximately 24 Weeks
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 1,500
Large-scale testing (Phase 3)Study completedNCT00369850
What this trial is testing

Bone Density and Bone Loss in Postmenopausal Women With Breast Cancer Receiving Treatment in Clinical Trial IBCSG-1-98

Who this might be right for
Breast CancerOsteoporosis
ETOP IBCSG Partners Foundation 458
Large-scale testing (Phase 3)WithdrawnNCT00888082
What this trial is testing

Protection of Ovarian Function With Goserelin Acetate in Premenopausal Early Breast Cancer Patients With Chemotherapy

Who this might be right for
Breast CancerOvarian Function
AstraZeneca 102
Not applicableUnknownNCT03743324
What this trial is testing

Effect of Radiation and Its Timing on Breast Reconstruction in Chinese Patients

Who this might be right for
Breast Cancer
Tianjin Medical University Cancer Institute and Hospital 1,344
Testing effectiveness (Phase 2)Study completedNCT00146562
What this trial is testing

Pegfilgrastim and Darbepoetin Alfa in Support of Adjuvant Chemotherapy for Breast Cancer

Who this might be right for
Breast CancerStage I Breast CancerStage II Breast Cancer
Harold J. Burstein, MD, PhD 135
Not applicableStudy completedNCT04148586
What this trial is testing

Trial Comparing 3 Schedules of Hypofractionated Whole Breast Irradiation in Females With Early Stage Breast Cancer

Who this might be right for
Breast Cancer Female
National Cancer Institute, Egypt 152
Large-scale testing (Phase 3)Study completedNCT04822597
What this trial is testing

Pain Control for Breast Cancer Patients Receiving Injection of Radioactive Tracer

Who this might be right for
Breast CancerSentinel Lymph NodeBreast Neoplasms+1 more
University of Wisconsin, Madison 167
Large-scale testing (Phase 3)Study completedNCT00055679
What this trial is testing

Combination Chemotherapy in Treating Women With Stage I Breast Cancer

Who this might be right for
Breast Cancer
UNICANCER 1,512
Not applicableLooking for participantsNCT05704062
What this trial is testing

Quantitative MRI Assessment of Breast Cancer Therapy Response

Who this might be right for
Breast Cancer
Corewell Health East 135
Testing effectiveness (Phase 2)Looking for participantsNCT05557877
What this trial is testing

Low Dose Aspirin for the Prevention of Postpartum Related Breast Cancer

Who this might be right for
Breast Carcinoma
Mayo Clinic 60
Early research (Phase 1)Ended earlyNCT04691375
What this trial is testing

PY314 in Subjects With Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorGynecologic CancerBreast Cancer+6 more
Ikena Oncology 86
Early research (Phase 1)Study completedNCT03538028
What this trial is testing

A Safety and Tolerability Study of INCAGN02385 in Select Advanced Malignancies

Who this might be right for
Cervical CancerMicrosatellite Instability (MSI)-High Endometrial CancerGastric Cancer (Including Stomach and Gastroesophageal Junction [GEJ])+14 more
Incyte Biosciences International Sàrl 22
Not applicableActive Not RecruitingNCT03657628
What this trial is testing

Physical Activity, Proliferation and Immune Markers in Benign Breast Tissue

Who this might be right for
Breast Cancer
Dana-Farber Cancer Institute 60
Not applicableActive Not RecruitingNCT06190600
What this trial is testing

Supervised Physical Activity in Young Women With Early Breast Cancer During Neoadjuvant Chemotherpy

Who this might be right for
Breast Cancer
The Greater Poland Cancer Centre 40
Not applicableStudy completedNCT04767607
What this trial is testing

Study of Prediction of Ovarian Reserve in Yong Breast Cancer Patients Treated With Chemotherapy

Who this might be right for
Breast Cancer
International Peace Maternity and Child Health Hospital 300
Not applicableWithdrawnNCT03523299
What this trial is testing

Pilot Study to Define the Immune Response Following Cryoablation of Invasive Breast Cancer

Who this might be right for
Invasive Ductal Carcinoma, Breast
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Testing effectiveness (Phase 2)UnknownNCT04213898
What this trial is testing

SHR-1210 Combined With Albumin-bound Paclitaxel and Epirubicin Neoadjuvant for Triple Negative Breast Cancer

Who this might be right for
Triple-negative Breast Cancer
Henan Cancer Hospital 39
Testing effectiveness (Phase 2)Ended earlyNCT00048893
What this trial is testing

Vaccine and Chemotherapy for Previously Untreated Metastatic Breast Cancer

Who this might be right for
Breast NeoplasmsMetastases, Neoplasm
National Cancer Institute (NCI) 37
Next Page